RheumNow Podcast Monitoring Methotrexate Safety (12.06.19)

This week covers the safety of biologic therapies for rheumatoid arthritis, spotlighting the risks of infections linked to methotrexate. It challenges previous beliefs about osteoporosis from proton pump inhibitors while stressing the importance of early DMARD treatment. Guidelines for monitoring methotrexate focus on liver health, and the efficacy of secukinumab in treating spine-related issues is celebrated. A long-term study on methotrexate reveals intriguing insights about dosage effectiveness and the impact of smoking on disease activity.